Cargando…
RUNX1: an emerging therapeutic target for cardiovascular disease
Runt-related transcription factor-1 (RUNX1), also known as acute myeloid leukaemia 1 protein (AML1), is a member of the core-binding factor family of transcription factors which modulate cell proliferation, differentiation, and survival in multiple systems. It is a master-regulator transcription fac...
Autores principales: | Riddell, Alexandra, McBride, Martin, Braun, Thomas, Nicklin, Stuart A, Cameron, Ewan, Loughrey, Christopher M, Martin, Tamara P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314639/ https://www.ncbi.nlm.nih.gov/pubmed/32154891 http://dx.doi.org/10.1093/cvr/cvaa034 |
Ejemplares similares
-
Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction
por: McCarroll, Charlotte S., et al.
Publicado: (2018) -
G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
por: Divorty, Nina, et al.
Publicado: (2015) -
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019) -
RUNX‐mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins
por: Anderson, Gail, et al.
Publicado: (2017) -
Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model
por: McArthur, Lisa, et al.
Publicado: (2019)